lung cancer glutathione Targeting Metabolism: Partner in Crime in Anticancer Therapy An anticancer agent-loaded PLGA nanomedicine
An anticancer agent loaded PLGA nanomedicine with glutathione response and targeted delivery for the treatment of lung cancer Journal of Materials Chemistry B (RSC Publishing) low glutathione and lung cancer Increased antioxidative defense reduced advanced glycation end product formation by metabolic adaptation in non small cell lung cancer patients Excessive glutathione intake contributes to Application of glutathione depletion in cancer therapy: Enhanced ROS based therapy, ferroptosis, and chemotherapy ScienceDirect International Journal of Molecular Medicine
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22


